25 May 2013
Keywords: ks, biomedix, rheumatoid, arthritis, study, positive, uk
Article | 12 February 1998
UK biotechnology firm KS Biomedix has reported positive data from aPhase II trial of CBF-BS2, a glucose-6-phosphate dehydrogenase
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 February 1998
11 February 1998
24 May 2013
© 2013 thepharmaletter.com